S Paradela1, E Fonseca, S Pita-Fernández, V G Prieto. 1. Department of Dermatology, University Hospital of La Coruña, La Coruña, Spain Departments of Pathology and Dermatology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA Department of Clinical-Epidemiology, University Hospital of La Coruña, La Coruña, Spain.
Abstract
BACKGROUND: Spitzoid melanoma is a rare melanoma subtype often developing in children with unknown biological potential. OBJECTIVES: To compare the clinical and histopathological factors that influence the biological behaviour between spitzoid and non-spitzoid childhood melanoma, to establish if the spitzoid subset of melanoma has different prognosis than other types of childhood melanomas. METHODS: A comparison of the prognostic significance of clinical and pathological findings between 38 spitzoid (SM) and 99 non-spitzoid melanomas (N-SM) in children and teenagers younger than 18 years referred to UT - MD Anderson Cancer Center during the period 1992-2007. RESULTS: Children with SM were significantly younger than those with N-SM, had more frequently multiple melanocytic nevi, nodular melanoma subtype with vertical growth phase, high Breslow thickness and mitotic rate, positive sentinel lymph node biopsy and more advanced stage. N-SM had more often associated nevus. However, the mortality rate in the SM group was lower (5.9%) than in the N-SM group (12.0%). This study has two major limitations. Small size of both groups does not allow reaching statistically significant differences regarding mortality. Using metastatic potential as an inclusion criterion for SM could result in a sample selection bias of the most aggressive group of SM. CONCLUSIONS: Although SM patients had poorer prognostic factors than N-SM patients, slightly lower mortality rate was detected in the SM group. This less aggressive behaviour could be due to lower potential for widespread distant metastases than conventional melanomas or younger age of children with SM.
BACKGROUND:Spitzoid melanoma is a rare melanoma subtype often developing in children with unknown biological potential. OBJECTIVES: To compare the clinical and histopathological factors that influence the biological behaviour between spitzoid and non-spitzoid childhood melanoma, to establish if the spitzoid subset of melanoma has different prognosis than other types of childhood melanomas. METHODS: A comparison of the prognostic significance of clinical and pathological findings between 38 spitzoid (SM) and 99 non-spitzoid melanomas (N-SM) in children and teenagers younger than 18 years referred to UT - MD Anderson Cancer Center during the period 1992-2007. RESULTS:Children with SM were significantly younger than those with N-SM, had more frequently multiple melanocytic nevi, nodular melanoma subtype with vertical growth phase, high Breslow thickness and mitotic rate, positive sentinel lymph node biopsy and more advanced stage. N-SM had more often associated nevus. However, the mortality rate in the SM group was lower (5.9%) than in the N-SM group (12.0%). This study has two major limitations. Small size of both groups does not allow reaching statistically significant differences regarding mortality. Using metastatic potential as an inclusion criterion for SM could result in a sample selection bias of the most aggressive group of SM. CONCLUSIONS: Although SM patients had poorer prognostic factors than N-SMpatients, slightly lower mortality rate was detected in the SM group. This less aggressive behaviour could be due to lower potential for widespread distant metastases than conventional melanomas or younger age of children with SM.
Authors: Hadeel Halalsheh; Sue C Kaste; Fariba Navid; Armita Bahrami; Barry L Shulkin; Bhaskar Rao; Michelle Kunkel; Nathan Artz; Alberto Pappo Journal: Pediatr Blood Cancer Date: 2018-08-19 Impact factor: 3.167
Authors: Rossitza Lazova; Erin H Seeley; Heinz Kutzner; Richard A Scolyer; Glynis Scott; Lorenzo Cerroni; Isabella Fried; Milena E Kozovska; Arlene S Rosenberg; Victor G Prieto; Bahig M Shehata; Megan M Durham; Gina Henry; Jose L Rodriguez-Peralto; Erica Riveiro-Falkenbach; Jochen T Schaefer; Richard Danialan; Sylvie Fraitag; Sonja Vollenweider-Roten; Alireza Sepehr; Martin Sangueza; Nouf Hijazi; Yamile Corredoira; Rachel Kowal; Olga M Harris; Francisco Bravo; Alan S Boyd; Ralitza Gueorguieva; Richard M Caprioli Journal: J Am Acad Dermatol Date: 2016-08-05 Impact factor: 11.527
Authors: Shyam S Raghavan; Sandra Peternel; Thaddeus W Mully; Jeffrey P North; Laura B Pincus; Philip E LeBoit; Timothy H McCalmont; Boris C Bastian; Iwei Yeh Journal: Mod Pathol Date: 2020-01-03 Impact factor: 7.842